Overcoming the Regulatory Challenges of Oligonucleotide Therapy CMC
Virtual Programs 
APIsBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and ControlVirtual Programs APIsBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and Control